| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/12/2001 | US6245752 Antigenic carbohydrate determinant; anticarcinogenic agents |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245353 Mixing with effervescent base |
| 06/12/2001 | US6245334 Polypeptide containing lecithin |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/12/2001 | CA2195031C Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040988A1 Web map tool |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040445A1 Cell isolation method |
| 06/07/2001 | WO2001040438A2 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040298A1 A new polypeptide - human protein kinase 9 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040295A1 A new polypeptide - human zinc finger protein 48 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040266A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040240A2 Mono- and disaccharide derivatives |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040229A2 Method for producing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | WO2001040211A1 A PROCESS FOR THE PREPARATION OF {2-[4-(α-PHENYL-p-CHLOROBENZYL)PIPERAZIN-1-YL]ETHOXY}ACETIC ACID AND NOVEL INTERMEDIATES THEREFOR |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001039803A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 06/07/2001 | WO2001039800A2 Controlled delivery of antigens |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001013946A3 Method for isolating and purifying grass pollen allergens |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO1999052548A9 Conjugate vaccines for the prevention of dental caries |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | DE19958460A1 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation Process for preparing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | DE19957904A1 Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung Insect venom allergens with reduced IgE-reactivity, and methods for their preparation |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | CA2392958A1 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/06/2001 | EP1104767A1 Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| 06/06/2001 | EP1104764A1 1h-imidazopyridine derivatives |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104461A1 Grip, human adapter protein related to the grb2 family member |
| 06/06/2001 | EP1104446A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104306A1 Compositions of cpg and saponin adjuvants and methods thereof |
| 06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
| 06/06/2001 | EP0773786B1 Quinoa saponin compositions and methods of use |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/06/2001 | CN1298307A Enhancement of immunity by intranasal inoculation of IL-12 |
| 06/06/2001 | CN1298008A Human protein kinase 9 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297935A Human zinc-finger protein 48 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297919A Human zinc-finger protein 69 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297915A Human zinc-finger protein 46 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297914A Human zinc-finger protein 58 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297905A Human ribosomal protein L14.22 as one new kind of polypeptide and polynuceotides encoding this polypeptide |
| 06/06/2001 | CN1297776A Medicine for resisting acute exclusiveness and raising activity level of complement during organ transplantation |
| 06/06/2001 | CN1297754A Tonic food capable of lowering blood lipoid, resisting senility and regulating immunity |
| 06/06/2001 | CN1297743A Buccal tablet of Qingqian Willow leaf |
| 06/06/2001 | CN1066728C Process for producing epoxide |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |